MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

Search

Cartesian Therapeutics Inc

Geschlossen

13 -0.08

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

12.77

Max

13.38

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+199.02% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

6. Aug. 2025

Cartesian Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

14. Juli 2025, 22:07 UTC

Wichtige Markttreiber

Trade Desk Rises on S&P 500 Inclusion

14. Juli 2025, 17:06 UTC

Wichtige Markttreiber

Crypto Assets Rally Ahead of Possible U.S. Legislation

14. Juli 2025, 16:47 UTC

Akquisitionen, Fusionen, Übernahmen

NatWest to Sell Stake in Permanent TSB

14. Juli 2025, 23:46 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

14. Juli 2025, 23:38 UTC

Market Talk

Gold Edges Higher Ahead of U.S. CPI Data -- Market Talk

14. Juli 2025, 23:37 UTC

Market Talk

ANZ's Institutional Earnings Likely to Weigh on Outlook -- Market Talk

14. Juli 2025, 23:29 UTC

Market Talk

South32 Bull Eyes Possible Last-Minute Power Deal for Mozal -- Market Talk

14. Juli 2025, 23:29 UTC

Market Talk

Global Energy Roundup: Market Talk

14. Juli 2025, 23:02 UTC

Ergebnisse

China Vanke: Additional Provision for Asset Impairment Also Among Factors Weighing on Results >000002.SZ

14. Juli 2025, 23:02 UTC

Ergebnisse

China Vanke: Weakness in Overall China Real-Estate Sector Weighed on Results >000002.SZ

14. Juli 2025, 23:02 UTC

Ergebnisse

China Vanke 1H Loss Was CNY9.85B >000002.SZ

14. Juli 2025, 23:01 UTC

Ergebnisse

China Vanke Sees 1H Loss CNY10.0B-Loss CNY12.0B >000002.SZ

14. Juli 2025, 23:01 UTC

Ergebnisse

China Vanke Expects 1H Loss to Widen >000002.SZ

14. Juli 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

14. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14. Juli 2025, 20:07 UTC

Market Talk

Cloud Computing Giants Will Be the Winner from Software's Loss -- Market Talk

14. Juli 2025, 20:05 UTC

Market Talk

Adobe and Salesforce May Struggle to Keep Up With AI Agents -- Market Talk

14. Juli 2025, 19:11 UTC

Market Talk

Oil Retreats Despite Trump Threats of Russia Sanctions -- Market Talk

14. Juli 2025, 19:09 UTC

Market Talk

Gold Breaks a 3-Day Win Streak -- Market Talk

14. Juli 2025, 18:59 UTC

Market Talk

Hotter Weather Outlook, LNG Flows Boost U.S. Natural Gas -- Market Talk

14. Juli 2025, 18:30 UTC

Akquisitionen, Fusionen, Übernahmen

Synopsys Buy of Ansys Gets China OK. The $35 Billion Deal Is Set to Close. -- Barrons.com

14. Juli 2025, 18:25 UTC

Market Talk

Dollar Gains, Treasury Yields Lose Steam as Trump Threatens Russia -- Market Talk

14. Juli 2025, 18:25 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14. Juli 2025, 16:59 UTC

Market Talk

Goldman Sachs Lifts 2H25 Crude Price Views -- Market Talk

14. Juli 2025, 16:53 UTC

Heiße Aktien

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14. Juli 2025, 16:27 UTC

Market Talk

Oil Falls as Investors Monitor U.S.-EU Trade, Trump's Russia Sanction Threats -- Market Talk

14. Juli 2025, 16:20 UTC

Market Talk
Ergebnisse

Auto & Transport Roundup: Market Talk

14. Juli 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

14. Juli 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

14. Juli 2025, 16:12 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

Peer-Vergleich

Kursveränderung

Cartesian Therapeutics Inc Prognose

Kursziel

By TipRanks

199.02% Vorteil

12-Monats-Prognose

Durchschnitt 39.83 USD  199.02%

Hoch 42 USD

Tief 38 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Cartesian Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

7 ratings

7

Buy

0

Halten

0

Sell

Finanzen

$